Working… Menu

Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir (NewHorizon)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04194021
Recruitment Status : Recruiting
First Posted : December 11, 2019
Last Update Posted : February 8, 2021
Janssen, LP
Information provided by (Responsible Party):
Elizabeth Glaser Pediatric AIDS Foundation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2022